<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>59(9)</volume><submitter>Schroeder JC</submitter><journal>Bone marrow transplantation</journal><pagination>1332-1334</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11368806</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Superior outcome of upfront allogeneic hematopoietic cell transplantation versus hypomethylating agent induction in myelodysplastic syndrome.</pubmed_title><pmcid>PMC11368806</pmcid><pubmed_authors>Vogel W</pubmed_authors><pubmed_authors>Schroeder JC</pubmed_authors><pubmed_authors>Fehn A</pubmed_authors><pubmed_authors>Faul C</pubmed_authors><pubmed_authors>Bethge WA</pubmed_authors><pubmed_authors>Mix L</pubmed_authors><pubmed_authors>Riedel A</pubmed_authors><pubmed_authors>Faustmann P</pubmed_authors><pubmed_authors>Weller JF</pubmed_authors><pubmed_authors>Phely L</pubmed_authors><pubmed_authors>Lengerke C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Superior outcome of upfront allogeneic hematopoietic cell transplantation versus hypomethylating agent induction in myelodysplastic syndrome.</name><description/><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2025-04-26T03:39:00.835Z</modification><creation>2025-04-06T10:49:03.445Z</creation></dates><accession>S-EPMC11368806</accession><cross_references><pubmed>38982155</pubmed><doi>10.1038/s41409-024-02365-5</doi></cross_references></HashMap>